A retrospective analysis of the obliteration rate after stereotactic radiotherapy using different radiation dose schedules in intracranial arteriovenous malformatio

Completed

• Conditions: Brain Arteriovenous Malformation that used Hypofractionated radiation method for treatment.; Arteriovenous Malformation, Intracranial; Intracranial Arteriovenous Malformation; Malformation, Intracranial Arteriovenous; Malformations, Intracranial Arteriovenous; AVM (Arteriovenous Malformation) Intracranial; Congenital Intracranial Arteriovenous Malformations; Intracranial Arteriovenous Malformations, Congenital; Arteriovenous Malformations, Cerebral; Cerebral Arteriovenous Malformation

• Registration Number: TCTR20240608005
• Lead Sponsor: Department of Radiology, Faculty of Medicine Chiang Mai University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2023-12-30
• Study Start: 2024-06-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 87

Inclusion Criteria

1. Patients who underwent SRT during 2014 to 2021, 2. Patients who had a complete medical record and imaging investigations both before and after SRT were enrolled for analysis, 3. patients who received a 30-36 Gy regimen or a 28 Gy regimen.

Exclusion Criteria

1.Patients who have Incomplete SRT dose, 2. Patients who lost of follow up, 3.Patients who have Incomplete Imaging investigation.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
obliteration rate at 3 years 3 years after receiving SRT obliteration rate

Secondary Outcome Measures

Name	Time	Method
median time to obliteration since patients receive SRT until the follow up imaging shows no AVM left Time in month, count since patients receive SRT until the follow up imaging shows no AVM left